Home > Insider Trading > Filing (0001209191-20-028898)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1567514	Intra-Cellular Therapies Inc.	ITCI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1316274	A Richard Lerner	C/O Intra-Cellular Therapies, Inc. 430 East 29Th Street New York NY 10016		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-05-11	25,000	$2.74	97,313	No	4	M	Indirect	Held by the Lerner Family Trust UAD 11/14/94
Common Stock	Disposition	2020-05-11	3,500	$20.50	93,813	No	4	S	Indirect	Held by the Lerner Family Trust UAD 11/14/94

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Indirect	Held by the Lerner Family Trust UAD 11/14/94
No	4	S	Indirect	Held by the Lerner Family Trust UAD 11/14/94

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-05-11	12,500	$0.00	12,500	$2.74
Common Stock	Stock Option (right to buy)	Disposition	2020-05-11	12,500	$0.00	12,500	$2.74

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2020-06-10	No	4	M	Direct
0		2020-12-21	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	11,430	Direct

Footnotes

Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein.
The proceeds from this sale will be used primarily to cover the reporting person's tax liability arising from the exercise of options.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.50 to $20.51 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
All shares underlying this option have vested.